Caley-Reidenbach Consulting, LLP
541-929-7435
contact AT caleyreidenbach.com 

Neurology/Pain/Psychiatry

General

  • "Neurologic Diseases and Disorders" (slide set). American Geriatrics Society, December 2004. [BAC and FR,writers]

  • Reidenbach F. General health care resources: neurology, neuroscience, and neurosurgery. In: Gibbs SR, Sullivan-Fowler M, Rowe NW, eds. Medical Surfari: A Guide to Exploring the Internet and Discovering the Top Health Care Resources. St. Louis: Mosby Year-Book; 1996.

Addiction

  • Section 3 (review of clinical evidence) of an AMCP dossier about a drug for maintenance treatment of opioid dependence. Prepared June 2014. [FR, writer]

  • Clinical trial report on a protocol for treating methamphetamine dependence. Prepared June 2006. [FR, collaborating writer]

  • "Addictions" (slide set). American Geriatrics Society, March 2008. [BAC and FR,writers]

  • Reidenbach F. Lower-status monkeys more likely to use cocaine. Reuters news for physicians, 1-21-2002.

Alzheimer's disease see Dementia

Anxiety

  • "Anxiety Disorders" (slide set). American Geriatrics Society, March 2008. [BAC and FR,writers]

  • Reidenbach F. Substance P antagonists have antidepressant, anxiolytic effects. Reuters news for physicians, 9-11-1998.

Attention deficit hyperactivity disorder

  • Attended and reported on an advisory board meeting about a novel nicotinic receptor agonist and its potential role in the treatment of attention deficit hyperactivity disorder, April 2012. [FR, writer]

  • 2 posters about modafinil-ADHD presented at the 2006 annual meeting of the American Academy of Pediatrics. [FR, collaborating writer]

  • Current, new, and emerging treatment options in ADHD: focus on dosing and duration of effect. CME slide set prepared August 2006. [FR, writer]

  • Reidenbach F. Serotonin may mediate calming effect of stimulants in patients with ADHD. Reuters news for physicians, 1-15-1999.

  • Reidenbach F. ADHD not overdiagnosed. Reuters news for the public, 4-7-1998.

  • Reidenbach F. What optometrists should know about attention-deficit hyperactivity disorder. Pediatric Optometry. 1992;2(2):8.

Autism

  • Reidenbach F. Often possible to detect autism cause. Reuters news for the public, 3-14-2002.

Bipolar disorder

  • Needs assessment for a CME program about depression in bipolar disorder type II. Prepared October 2014. [FR, writer]

  • Series of 24 reports on regional advisory board meetings, and portions of 24 corresponding physician newsletters, regarding antipsychotic treatment of schizophrenia and bipolar disorder. Prepared December 2006 to April 2007. [BAC, writer]

  • Patient and physician perspectives on nonadherence with treatment for bipolar disorder: results of a multinational survey. Journal article prepared November 2006. [FR, collaborating writer]

  • Reidenbach F. Migraine more common in bipolar II than in other affective disorders. Reuters news for physicians, 1-21-2002.

Dementia

  • 5 slide decks designed to help nurses at long-term-care facilities care for residents with dementia, with special attention to 13 quality measures of the Centers for Medicare and Medicaid Services. Topics: CNS issues (depression and use of antipsychotics); comfort (pain, pressure ulcers, weight loss); function (activities of daily living, falls, restraints); urinary issues (incontinence, catheterization, UTIs); and vaccinations. Prepared April to May 2013. [BAC and FR, writers]

  • Attended and reported on an advisory board meeting about a novel nicotinic receptor agonist and its potential role in the treatment of Alzheimer disease, April 2012. [FR, writer] 

  • "Behavioral Problems in Dementia" and "Dementia" (slide sets). American Geriatrics Society, May 2005 and March 2006. [BAC and FR, writers]

  • Smart choices can keep you smart [effect of lifestyle on preservation of cognitive function]. Prepared for Men's Health Advisor, June 2005. [BAC, writer]

  • Review article about the pharmacoeconomics of acetylcholinesterase inhibitors for patients with dementia. Prepared September 2003. [FR, collaborating writer]

  • Whitehouse PJ, Reidenbach F. Guidelines for early identification of Alzheimer disease. Alzheimer Dis Assoc Disorder. 1997;11:61-62.

  • Reidenbach F. Antagonism of gp120 might treat HIV-related cognitive impairment. Reuters news for physicians, 12-6-2002.

  • Reidenbach F. Aricept benefits patients with vascular dementia. Reuters news for physicians, 1-28-2002.

  • Reidenbach F. Genetic factors in Alzheimer’s disease have separate effects. Reuters news for physicians, 7-23-1998.

  • Alzheimer Disease and Associated Disorders (journal). FR was freelance production editor for Lippincott Raven, 1994-1997.

Depression

  • Needs assessment for CME program for psychiatrists and primary care physicians about recognition and treatment of major depressive disorder. Prepared April 2013. [BAC and FR, writers]

  • Gorman JM. Gender differences in depression and response to psychotropic medication. Gend Med. 2006;3:93-109. [FR, collaborating writer]

  • Medicine chest: Effexor, Cymbalta, and Remeron. Prepared for Men’s Health Advisor, June 2005. [BAC, writer]

  • Reidenbach F. Mental health care lacking for depressed HIV-infected nursing home residents. Reuters news for the public, 10-18-2002.

  • Reidenbach F. Nortriptyline plus psychotherapy prevents recurrent depression in older patients. Reuters news for physicians, 1-6-1999.

  • Reidenbach F. Depression tied to cancer risk in elderly. Reuters news for the public, 12-15-1998.

  • Reidenbach F. Severity of late-onset depression correlates with atrophy of prefrontal lobe. Reuters news for physicians, 6-23-1998.

Epilepsy

  • Needs assessment for CME program for neurologists about treatment of epilepsy. Prepared August 2014. [BAC, writer]

  • Needs assessment for CME program for neurologists on treatment of epilepsy. Prepared July 2012. [BAC and FR, writers]

  • Reidenbach F. New guidelines for choosing epilepsy medications. Cortlandt Forum. 2004;17(7):41-44.

  • Reidenbach F. Lorazepam more efficacious than phenytoin for overt status epilepticus. Reuters news for physicians, 9-17-1998.

Headache/Migraine

  • Mathew N, Katsarava Z, Tepper SJ, Reidenbach F, Porreca F. Medication overuse headache: basic and clinical considerations. In preparation.

  • Winner P, Woodruff B, Liss CL, Lillieborg S, Raines S. Efficacy and safety of zolmitriptan nasal spray for the treatment of acute migraine in adolescents. Poster presented at the American Headache Society annual meeting, June 2015. [FR, collaborating writer]

  • Tepper SJ, Chen S, Reidenbach F, Rapoport AM. Intranasal zolmitriptan for the treatment of acute migraine. Headache 2013;53(suppl 2):62-71.

  • Web-based news for physicians and patient education brochure about menstrual migraine. Prepared November 2007 to April 2008. [BAC and FR, writers]

  • Report for a pharmaceutical company summarizing its clinical trials of an anti-migraine drug. Prepared January 2003. [BAC and FR, researchers]

  • Reidenbach F. Reduced-dose flunarizine effective for migraine prophylaxis. Reuters news for physicians, 6-21-2002.

  • Reidenbach F. Migraine more common in bipolar II than in other affective disorders. Reuters news for physicians, 1-21-2002.

  • Reidenbach F. Triptans need not be first-line therapy for migraine. Reuters news for the public, 11-11-1998.

  • Reidenbach F. Frovatriptan safe, efficacious against migraine in preliminary studies. Reuters news for physicians, 6-29-1998.

Pain

Parkinson's disease

  • Beyond motor symptoms in Parkinson's disease. 3 CME slide presentations focusing on PD psychosis. Prepared June 2015. [FR, collaborating writer]

  • Henchcliffe C, Chen S. Prevalence and impact of Parkinson's disease symptoms: a patient survey across the range of disease severity. Poster presented at the 2013 World Parkinson Congress. [FR, collaborating writer]

  • Slide set about label changes to 2 drugs for Parkinson's disease. Prepared March 2009. [BAC, writer]

Personality and somatoform disorders

  • "Personality and Somatoform Disorders" (slide set). American Geriatrics Society, May 2008. [BAC and FR, writers]

Schizophrenia and other psychotic disorders

  • Needs assessment for a CME program for psychiatrists about diagnosis and treatment of schizophrenia. Prepared August 2012. [BAC and FR, writers]

  • Attended and reported on an advisory board meeting about a novel nicotinic receptor agonist and its potential role in the treatment of schizophrenia, April 2012. [FR, writer]

  • Attended and reported on 6 advisory board meetings about an atypical antipsychotic, Fall 2011. [BAC, writer]

  • Training module for sales representatives about antipsychotic medications. Prepared November 2007. [BAC, writer]

  • Series of 24 reports on regional advisory board meetings, and portions of 24 corresponding physician newsletters, regarding antipsychotic treatment of schizophrenia and bipolar disorder. Prepared December 2006 to April 2007. [BAC, writer]

  • "Psychotic Disorders" (slide set). American Geriatrics Society, April 2008. [BAC and FR, writers]

  • Review article about abnormalities of glucose metabolism associated with atypical antipsychotic drugs. Prepared September 2003. [FR, collaborating writer]

Sleep disorders

  • Review article about the role of modafinil in treating disorders of excessive sleepiness. Prepared April 2007. [FR, collaborating writer]

  • "Sleep Problems" (slide set). American Geriatrics Society, September 2006. [BAC and FR, writers]

Stroke

  • The impact of the use of stroke scales on patient outcomes. Review prepared October 2006. [FR, collaborating writer]

  • The use of stroke scales to evaluate stroke severity and treatment effect. Review prepared June 2006. [FR, collaborating writer]

  • Qualitative literature analysis about treatment of acute ischemic stroke. Prepared April 2006. [FR, researcher]

  • "Neurologic Diseases and Disorders" (slide set). American Geriatrics Society, December 2004. [BAC and FR, writers]

  • Protect yourself from heart attack and stroke. Prepared for Health Newsletters Direct, June 2004. [BAC and FR, writers]

  • Reidenbach F. High baseline systolic blood pressure predicts hemorrhage after streptokinase for stroke. Reuters news for physicians, 10-1-2002.

  • Reidenbach F. Prehospital fibrinolysis can be worthwhile even in urban areas. Reuters news for physicians, 7-23-2002.

  • Reidenbach F. Virtual reality therapy reduces hand impairment years after stroke. Reuters news for the public, 2-1-2002.

  • Reidenbach F. Pravastatin reduces stroke risk after MI even if lipid levels not high. Reuters news for physicians, 1-25-1999.

  • Reidenbach F. First neuron transplant performed for treatment of stroke. Reuters news for physicians, 7-9-1998.

  • Reidenbach F. Anticlotting drug doesn’t help stroke. Reuters news for the public, 4-21-1998.

  • Reidenbach F. Many stroke survivors do well. Reuters news for the public, 4-2-1998.

  • Reidenbach F. A revolution in treatment for stroke. Cleve Clin Heart Advisor. 1998:1(4):4-5.

Tourette's syndrome

  • Fox MR. Treatment of rage episodes with mecamylamine in children with Tourette's syndrome: two case reports. In preparation. [FR, collaborating writer]

Other

  • Quantitative literature review about a drug for the treatment of post-herpetic neuralgia. Prepared October 2007. [BAC, researcher]

  • Report on an advisory board meeting about therapeutic neurotoxin injection. Prepared July 2007. [FR, writer]

  • Nerve damage possible with two arthritis drugs. Reuters news for the public, 1-18-2002. [FR, writer]

  • Reidenbach F. Dental phobia in abuse survivors. Women’s Recovery Network. 1992;2(4):12-14.